VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC
Year: 2011
Type: article
Source: Clinical Cancer Research
Institution: University of Washington
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2121810724
